Onconetix, Inc. Quarterly Deferred Income Tax Expense (Benefit) in USD for Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
Onconetix, Inc. quarterly/annual Deferred Income Tax Expense (Benefit) history and growth rate for Q1 2024.
  • Onconetix, Inc. Deferred Income Tax Expense (Benefit) for the quarter ending March 31, 2024 was -$122K.
Deferred Income Tax Expense (Benefit), Quarterly (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 -$122K Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.